XML 66 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Employee Stock Compensation
 3 Months Ended
Apr. 30, 2013
Share-Based Arrangements With Employees and Nonemployees [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
8. Employee Stock Compensation

The Company has three main share-based payment plans: The Nonemployee Directors Option Plan (the “Directors Plan”) and two Restricted Stock Plans (the “2009 Equity Plan” and the “2012 Equity Plan”). Both the 2009 and 2012 Equity Plans have an identical structure. The below table summarizes the main provisions of each of these plans:

  

    Nature and terms
     
Nonemployee Director Stock Option Plan   The plan provides for an automatic one-time grant of options to purchase 5,000 shares of common stock to each nonemployee director newly elected or appointed. Options are granted at not less than fair market value, become exercisable commencing six months from the date of grant and expire six years from the date of grant. In addition, all nonemployee directors re-elected to the Company’s Board of Directors at any annual meeting of the stockholders will automatically be granted additional options to purchase 1,000 shares of common stock on that date. Such plan expired at December 31, 2012, as to any new awards. Existing options will expire based on individual award dates.
     
Restricted Stock Plan – employees   Long-term incentive compensation three-year plan. Employees are granted potential share awards at the beginning of the three-year cycle at baseline and maximum amounts.  The level of award and final vesting is based on the Board of Director’s opinion as to the performance of the Company and management in the entire three-year cycle.  All vesting is three-year “cliff” vesting - there is no early vesting. The valuation is based on the stock price at the grant date and amortized to expense over the three-year period.
     
Restricted Stock Plan – directors   Long-term incentive compensation three-year plan. Directors are granted potential share awards at the beginning of the three-year cycle at baseline and maximum amounts.  The level of award and final vesting is based on the Board of Director’s opinion as to the performance of the Company and management in the entire three-year cycle.  All vesting is three-year “cliff” vesting - there is no early vesting. The valuation is based on the stock price at the grant date and amortized to expense over the three-year period.
     
Matching award program   All participating employees are eligible to receive one share of restricted stock awarded for each two shares of Lakeland stock purchased on the open market. Such restricted shares are subject to three-year time vesting. The valuation is based on the stock price at the grant date and amortized to expense over the three-year period.
     
Compensation in stock in lieu of cash program - employees   All participating employees are eligible to elect to receive any cash bonus in shares of restricted stock.  Such restricted shares are subject to two-year time vesting. The valuation is based on the stock price at the grant date and amortized to expense over the two-year period. Since the employee is giving up cash for unvested shares, the amount of shares awarded is 133% of the cash amount based on the grant date stock price. The Chief Executive Officer, Chief Financial Officer and the Chief Operating Officer of the Company have all elected to take 30% of their cash compensation in restricted stock pursuant to this program, commencing in October 2012.
     
Director fee in stock program   All directors are eligible to elect to receive any director fees in shares of restricted stock.  Such restricted shares are subject to two-year time vesting. The valuation is based on the stock price at the grant date and amortized to expense over the two-year period.  Since the director is giving up cash for unvested shares, the amount of shares awarded is 133% of the cash amount based on the grant date stock price.

  

The following table represents our stock options granted, exercised and forfeited during the three months ended April 30, 2013.

 

Stock Options   Number
of Shares		     Weighted
Average
Exercise
Price per
Share		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value		  
Outstanding at January 31, 2013     24,000     $ 7.47       3.95 years     $ 1,300  
Granted during the three months ended April 30, 2013     —       —       —       —  
Outstanding at April 30, 2013     24,000     $ 7.47       3.70 years       —  
Exercisable at April 30, 2013     24,000     $ 7.47       3.70 years       —  
Reserved for future issuance:                                
Directors’ Plan (expired on December 31, 2012)     —                          

 

There were no exercises or forfeitures during the three-months ended April 30, 2013.

 

Restricted Stock Plan and Performance Equity Plan

 

On June 17, 2009, the stockholders of the Company approved a restricted stock plan (the “2009 Equity Plan”). A total of 253,000 shares of restricted stock were authorized under this plan. On June 20, 2012, the stockholders of the Company authorized 310,000 shares under a new restricted stock plan (the “2012 Equity Plan”). Under these restricted stock plans, eligible employees and directors are awarded performance-based restricted shares of the Company common stock. The amount recorded as expense for the performance-based grants of restricted stock are based upon an estimate made at the end of each reporting period as to the most probable outcome of this plan at the end of the three-year performance period (e.g., baseline, maximum or zero). In addition to the grants with vesting based solely on performance, certain awards pursuant to the plan have a time-based vesting requirement, under which awards vest from two to three years after grant issuance, subject to continuous employment and certain other conditions. Restricted stock has voting rights, and the underlying shares are not considered to be issued and outstanding until vested.

 

Under the 2009 Equity Incentive Plan, the Company has issued 162,495 fully vested shares as of April 30, 2013. The Company has granted up to a maximum of 20,365 restricted stock awards remaining unvested as of April 30, 2013. All of these restricted stock awards are nonvested at April 30, 2013, and have a weighted average grant date fair value of $8.06. The Company recognizes expense related to performance-based awards over the requisite service period using the straight-line attribution method based on the outcome that is probable.

 

Under the 2012 Equity Incentive Plan, the Company has granted 263,541 restricted stock awards as of April 30, 2013, assuming all maximum awards are achieved. All of these restricted stock awards are nonvested at April 30, 2013 (202,041 shares at “baseline”), and have a weighted average grant date fair value of $6.15. The Company recognizes expense related to performance-based awards over the requisite service period using the straight-line attribution method based on the outcome that is probable.

 

As of April 30, 2013, unrecognized stock-based compensation expense related to restricted stock awards totaled $16,502 pursuant to the 2009 Equity Incentive Plan and $1,422,981 pursuant to the 2012 Equity Incentive Plan, before income taxes, based on the maximum performance award level, less what has been charged to expense on a cumulative basis through April 30, 2013, which was set to zero. Such unrecognized stock-based compensation expense related to restricted stock awards totaled $16,502 for the 2009 Equity Incentive Plan and $1,026,921 for the 2012 Equity Incentive Plan at the baseline performance level. The cost of these nonvested awards is expected to be recognized over a weighted-average period of three years. The Board has estimated its current performance level to be at zero, and expenses have been recorded accordingly. The performance-based awards are not considered stock equivalents for earnings per share (“EPS”) calculation purposes.

 

Stock-Based Compensation

 

The Company recognized total stock-based compensation costs of $74,831 and $131,391 for the years ended April 30, 2013 and 2012, respectively, of which $0 and $131,391 result from the 2009 Equity Plan and $74,831 and $0 result from the 2012 Equity Plan for the years ended April 30, 2013 and 2012, respectively, and $0 and $0, respectively, from the Director Option Plan. These amounts are reflected in selling, general and administrative expenses. The total income tax benefit recognized for stock-based compensation arrangements was $26,939 and $47,300 for the years ended April 30, 2013 and 2012, respectively.

 

Shares under 2012 Equity
Plan		   Outstanding
unvested grants
at maximum(a) at
beginning of
FY14		     Granted
during FY14
through
April 30,
2013		     Vested
during FY14
through
April 30,
2013		     Forfeited
during FY14
through
April 30,
2013		     Outstanding
unvested
grants at
maximum(a) at
April 30, 2013		  
                               
Restricted stock grants - employees     164,500       —       —       —       164,500  
Restricted stock grants - directors     49,500       —       —       —       49,500  
Matching award program     —       —       —       —       —  
Compensation in stock in lieu of cash - employees     21,517       18,316       —       —       39,833  
Retainer in stock - directors     6,601       3,107       —       —       9,708  
Total restricted stock plan     242,118       21,423       —       —       263,541  
                                         
Weighted average grant date fair value   $ 6.34     $ 4.06       —       —     $ 6.15  

 

Shares under 2009 Equity
Plan		   Outstanding
unvested grants
at maximum(a) at
beginning of
FY14		     Granted
during FY14
through
April 30,
2013		     Vested
during FY14
through
April 30,
2013		     Forfeited
during FY14
through
April 30,
2013		     Outstanding
unvested
grants at
maximum(a) at
April 30, 2013		  
Restricted stock grants –employees     —       —       —       —       —  
Restricted stock grants – directors     —       —       —       —       —  
Matching award program     3,500       —       —       —       3,500  
Compensation in stock in lieu of cash - employees     26,090       —       14,494       —       11,596  
Retainer in stock - directors     6,688       —       1,419       —       5,269  
Total restricted stock plan     36,278       —       15,913       —       20,365  
                                         
Weighted average grant date fair value   $ 8.27       —     $ 8.54       —     $ 8.06  

 

(a) The Board has estimated the current performance level at zero and expenses have been recorded accordingly.